JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 mai 2026, 23:47 UTC

Câștiguri

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 mai 2026, 22:35 UTC

Câștiguri

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 mai 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 mai 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 mai 2026, 23:32 UTC

Câștiguri

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 mai 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 mai 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 mai 2026, 23:16 UTC

Achiziții, Fuziuni, Preluări

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 mai 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 mai 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3 mai 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 mai 2026, 22:20 UTC

Câștiguri

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 mai 2026, 22:08 UTC

Câștiguri

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 mai 2026, 22:05 UTC

Câștiguri

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 mai 2026, 22:05 UTC

Câștiguri

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 mai 2026, 22:05 UTC

Câștiguri

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 mai 2026, 22:04 UTC

Câștiguri

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 mai 2026, 22:03 UTC

Câștiguri

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 mai 2026, 22:03 UTC

Câștiguri

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 mai 2026, 22:02 UTC

Câștiguri

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 mai 2026, 22:02 UTC

Câștiguri

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 mai 2026, 22:02 UTC

Câștiguri

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 mai 2026, 22:01 UTC

Câștiguri

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 mai 2026, 22:01 UTC

Câștiguri

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 mai 2026, 22:01 UTC

Câștiguri

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 mai 2026, 15:06 UTC

Câștiguri

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat